ESR1 and breast carcinoma: The specificity of the ERα antibody was further confirmed using the established breast cancer cell lines MCF7 (ERα-positive) and MDA-MB-231 (ERα-negative) (Supplemental Figure 1A; supplemental material available online with this article; https://doi.org/10.1172/JCI170809DS1).